Cited by 195Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and MyoclonusAutophagy in Disease and Therapy

Genetic and Chemical Correction of Cholesterol Accumulation and Impaired Autophagy in Hepatic and Neural Cells Derived from Niemann-Pick Type C Patient-Specific iPS Cells

Open access
Maetzel, Dorothea, Sarkar, Sovan, Wang, Haoyi, Abi-Mosleh, Lina, Xu, Ping, Cheng, Albert W., Gao, Qing, Mitalipova, Maisam +1 more·2014·Stem Cell Reports

Abstract

Niemann-Pick type C (NPC) disease is a fatal inherited lipid storage disorder causing severe neurodegeneration and liver dysfunction with only limited treatment options for patients. Loss of NPC1 function causes defects in cholesterol metabolism and has recently been implicated in deregulation of autophagy. Here, we report the generation of isogenic pairs of NPC patient-specific induced pluripotent stem cells (iPSCs) using transcription activator-like effector nucleases (TALENs). We observed decreased cell viability, cholesterol accumulation, and dysfunctional autophagic flux in NPC1-deficient human hepatic and neural cells. Genetic correction of a disease-causing mutation rescued these defects and directly linked NPC1 protein function to impaired cholesterol metabolism and autophagy. Screening for autophagy-inducing compounds in disease-affected human cells showed cell type specificity. Carbamazepine was found to be cytoprotective and effective in restoring the autophagy defects in both NPC1-deficient hepatic and neuronal cells and therefore may be a promising treatment option with overall benefit for NPC disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.stemcr.2014.03.014

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cholesterol accumulation in lysosomes impairs lysosomal functions, including autophagy-mediated mitochondrial degradation, in various pathological conditions, including Niemann-Pick disease type C.

    “Cholesterol accumulation in lysosomes has been shown to impair lysosomal functions, including autophagy-mediated mitochondrial degradation, in various pathological conditions, including Niemann-Pick disease type C.15”

    From ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes (2023) · cites this paper as [15]

    The Results section on the NPC1 mutation reports both cholesterol accumulation and impaired autophagic flux, but says that depleting cholesterol did not rescue the autophagy defect. It instead links the defect to loss of NPC1 function, contrary to the claimed causal role of cholesterol accumulation in NPC. The paper does not specifically report impaired autophagy-mediated mitochondrial degradation. (LLM, conf=0.85)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 46

  1. Abi-Mosleh L. Infante R.E. Radhakrishnan A. Goldstein J.L. Brown M.S. Cyclodextrin overcomes deficient lysosome-to-endoplasmic reticulum transport of cholesterol in Niemann-Pick type C cells Proc. Natl. Acad. Sci. USA 106 2009 19316 19321 19884502 PMC2780767
  2. Bjørkøy G. Lamark T. Pankiv S. Øvervatn A. Brech A. Johansen T. Monitoring autophagic degradation of p62/SQSTM1 Methods Enzymol. 452 2009 181 197 19200883
  3. Brown M.S. Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor Cell 89 1997 331 340 9150132
  4. Carstea E.D. Morris J.A. Coleman K.G. Loftus S.K. Zhang D. Cummings C. Gu J. Rosenfeld M.A. Pavan W.J. Krizman D.B. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis Science 277 1997 228 231 9211849
  5. Cermak T. Doyle E.L. Christian M. Wang L. Zhang Y. Schmidt C. Baller J.A. Somia N.V. Bogdanove A.J. Voytas D.F. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting Nucleic Acids Res. 39 2011 e82 21493687 PMC3130291
  6. Elrick M.J. Yu T. Chung C. Lieberman A.P. Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease Hum. Mol. Genet. 21 2012 4876 4887 22872701 PMC3607480
  7. Gelsthorpe M.E. Baumann N. Millard E. Gale S.E. Langmade S.J. Schaffer J.E. Ory D.S. Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding J. Biol. Chem. 283 2008 8229 8236 18216017 PMC2276376
  8. Goldstein J.L. Basu S.K. Brown M.S. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells Methods Enzymol. 98 1983 241 260 6321901
  9. Grskovic M. Javaherian A. Strulovici B. Daley G.Q. Induced pluripotent stem cells—opportunities for disease modelling and drug discovery Nat. Rev. Drug Discov. 10 2011 915 929 22076509
  10. Guschin D.Y. Waite A.J. Katibah G.E. Miller J.C. Holmes M.C. Rebar E.J. A rapid and general assay for monitoring endogenous gene modification Methods Mol. Biol. 649 2010 247 256 20680839
  11. Hara T. Nakamura K. Matsui M. Yamamoto A. Nakahara Y. Suzuki-Migishima R. Yokoyama M. Mishima K. Saito I. Okano H. Mizushima N. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice Nature 441 2006 885 889 16625204
  12. Hidvegi T. Ewing M. Hale P. Dippold C. Beckett C. Kemp C. Maurice N. Mukherjee A. Goldbach C. Watkins S. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis Science 329 2010 229 232 20522742
  13. Komatsu M. Liver autophagy: physiology and pathology J. Biochem. 152 2012 5 15 22661765
  14. Komatsu M. Waguri S. Chiba T. Murata S. Iwata J. Tanida I. Ueno T. Koike M. Uchiyama Y. Kominami E. Tanaka K. Loss of autophagy in the central nervous system causes neurodegeneration in mice Nature 441 2006 880 884 16625205
  15. Komatsu M. Waguri S. Koike M. Sou Y.S. Ueno T. Hara T. Mizushima N. Iwata J. Ezaki J. Murata S. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice Cell 131 2007 1149 1163 18083104
  16. Korolchuk V.I. Mansilla A. Menzies F.M. Rubinsztein D.C. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates Mol. Cell 33 2009 517 527 19250912 PMC2669153
  17. Kulinski A. Vance J.E. Lipid homeostasis and lipoprotein secretion in Niemann-Pick C1-deficient hepatocytes J. Biol. Chem. 282 2007 1627 1637 17107950
  18. Marchetto M.C. Carromeu C. Acab A. Yu D. Yeo G.W. Mu Y. Chen G. Gage F.H. Muotri A.R. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells Cell 143 2010 527 539 21074045 PMC3003590
  19. Meske V. Erz J. Priesnitz T. Ohm T.G. The autophagic defect in Niemann-Pick disease type C neurons differs from somatic cells and reduces neuronal viability Neurobiol. Dis. 64 2014 88 97 24412309
  20. Millard E.E. Gale S.E. Dudley N. Zhang J. Schaffer J.E. Ory D.S. The sterol-sensing domain of the Niemann-Pick C1 (NPC1) protein regulates trafficking of low density lipoprotein cholesterol J. Biol. Chem. 280 2005 28581 28590 15908696
  21. Miller J.C. Tan S. Qiao G. Barlow K.A. Wang J. Xia D.F. Meng X. Paschon D.E. Leung E. Hinkley S.J. A TALE nuclease architecture for efficient genome editing Nat. Biotechnol. 29 2011 143 148 21179091
  22. Mizushima N. Levine B. Cuervo A.M. Klionsky D.J. Autophagy fights disease through cellular self-digestion Nature 451 2008 1069 1075 18305538 PMC2670399
  23. Moscou M.J. Bogdanove A.J. A simple cipher governs DNA recognition by TAL effectors Science 326 2009 1501 19933106
  24. Ordonez M.P. Roberts E.A. Kidwell C.U. Yuan S.H. Plaisted W.C. Goldstein L.S. Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann Pick type C1 Hum. Mol. Genet. 21 2012 2651 2662 22437840 PMC3363339
  25. Ouimet M. Autophagy in obesity and atherosclerosis: Interrelationships between cholesterol homeostasis, lipoprotein metabolism and autophagy in macrophages and other systems Biochim. Biophys. Acta 1831 2013 1124 1133 23545567
  26. Pacheco C.D. Kunkel R. Lieberman A.P. Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects Hum. Mol. Genet. 16 2007 1495 1503 17468177
  27. Peake K.B. Vance J.E. Normalization of cholesterol homeostasis by 2-hydroxypropyl-β-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice J. Biol. Chem. 287 2012 9290 9298 22277650 PMC3308731
  28. Ravikumar B. Sarkar S. Davies J.E. Futter M. Garcia-Arencibia M. Green-Thompson Z.W. Jimenez-Sanchez M. Korolchuk V.I. Lichtenberg M. Luo S. Regulation of mammalian autophagy in physiology and pathophysiology Physiol. Rev. 90 2010 1383 1435 20959619
  29. Rosenbaum A.I. Maxfield F.R. Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches J. Neurochem. 116 2011 789 795 20807315 PMC3008286
  30. Rubinsztein D.C. Codogno P. Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases Nat. Rev. Drug Discov. 11 2012 709 730 22935804 PMC3518431
  31. Saha K. Jaenisch R. Technical challenges in using human induced pluripotent stem cells to model disease Cell Stem Cell 5 2009 584 595 19951687 PMC2921621
  32. Sarkar S. Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers Biochem. Soc. Trans. 41 2013 1103 1130 24059496
  33. Sarkar S. Floto R.A. Berger Z. Imarisio S. Cordenier A. Pasco M. Cook L.J. Rubinsztein D.C. Lithium induces autophagy by inhibiting inositol monophosphatase J. Cell Biol. 170 2005 1101 1111 16186256 PMC2171537
  34. Sarkar S. Carroll B. Buganim Y. Maetzel D. Ng A.H. Cassady J.P. Cohen M.A. Chakraborty S. Wang H. Spooner E. Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease Cell Rep. 5 2013 1302 1315 24290752 PMC3957429
  35. Si-Tayeb K. Noto F.K. Nagaoka M. Li J. Battle M.A. Duris C. North P.E. Dalton S. Duncan S.A. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells Hepatology 51 2010 297 305 19998274 PMC2946078
  36. Singh R. Cuervo A.M. Lipophagy: connecting autophagy and lipid metabolism Int. J. Cell Biol. 2012 2012 282041 22536247 PMC3320019
  37. Singh R. Kaushik S. Wang Y. Xiang Y. Novak I. Komatsu M. Tanaka K. Cuervo A.M. Czaja M.J. Autophagy regulates lipid metabolism Nature 458 2009 1131 1135 19339967 PMC2676208
  38. Soldner F. Jaenisch R. Medicine. iPSC disease modeling Science 338 2012 1155 1156 23197518
  39. Soldner F. Hockemeyer D. Beard C. Gao Q. Bell G.W. Cook E.G. Hargus G. Blak A. Cooper O. Mitalipova M. Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors Cell 136 2009 964 977 19269371 PMC2787236
  40. Soldner F. Laganière J. Cheng A.W. Hockemeyer D. Gao Q. Alagappan R. Khurana V. Golbe L.I. Myers R.H. Lindquist S. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations Cell 146 2011 318 331 21757228 PMC3155290
  41. Sommer C.A. Mostoslavsky G. Experimental approaches for the generation of induced pluripotent stem cells Stem Cell Res. Ther. 1 2010 26 20699015 PMC2941118
  42. Trilck M. Hübner R. Seibler P. Klein C. Rolfs A. Frech M.J. Niemann-Pick type C1 patient-specific induced pluripotent stem cells display disease specific hallmarks Orphanet J. Rare Dis. 8 2013 144 24044630 PMC3848807
  43. Vance J.E. Peake K.B. Function of the Niemann-Pick type C proteins and their bypass by cyclodextrin Curr. Opin. Lipidol. 22 2011 204 209 21412152
  44. Vanier M.T. Niemann-Pick disease type C Orphanet J. Rare Dis. 5 2010 16 20525256 PMC2902432
  45. Xie C. Turley S.D. Pentchev P.G. Dietschy J.M. Cholesterol balance and metabolism in mice with loss of function of Niemann-Pick C protein Am. J. Physiol. 276 1999 E336 E344 9950794
  46. Yusa K. Rashid S.T. Strick-Marchand H. Varela I. Liu P.Q. Paschon D.E. Miranda E. Ordóñez A. Hannan N.R. Rouhani F.J. Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells Nature 478 2011 391 394 21993621 PMC3198846

Cited by

Sorted by citations

Authors
Maetzel, D., Sarkar, S., Wang, H., Abi-Mosleh, L., Xu, P., Cheng, A. W., Gao, Q., Mitalipova, M., & Jaenisch, R.
Affiliations
  • Whitehead Institute for Biomedical Research (US)
  • The University of Texas Southwestern Medical Center (US)
  • Skolkovo Institute of Science and Technology (RU)
Corresponding author
Jaenisch, Rudolf
Venue
Stem Cell Reports
Publisher
Elsevier BV
Published
2014-06
Volume
2
Issue
6
Pages
866-880
ISSN
2213-6711 (ISSN-L)
OpenAlex
W2096912149
Cited by
195
References
7
Citations by year
2026: 7 · 2025: 5 · 2024: 7 · 2023: 10 · 2022: 14 · 2021: 24 · 2020: 19 · 2019: 13 · 2018: 17 · 2017: 23 · 2016: 29 · 2015: 17 · 2014: 10
FWCI
16.40
Type
journal article
Language
en
Open access
Locations
  • Stem Cell Reports (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc-nd)
Funders
  • Massachusetts Institute of Technology
  • National Institutes of Health (2r01ca084198-10)
  • National Heart, Lung, and Blood Institute (HL-20948, P01HL020948)
  • National Cancer Institute (R01-CA084198, P30CA014051)
Topics
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
  • Health Sciences › Medicine › Rheumatology › Glycogen Storage Diseases and Myoclonus
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
Keywords
Niemann-Pick disease type C, NPC1, induced pluripotent stem cells, TALEN genome editing, cholesterol accumulation, autophagy, autophagic flux, hepatocytes, neurons, carbamazepine, cell type specificity, cytoprotection, lipid storage disease, neurodegeneration
MeSH terms
Adult, Autophagy, Cells, Cultured, Child, Child, Preschool, Cholesterol, Humans, Neurons, Hepatocytes, Niemann-Pick Disease, Type C, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review